Ivan Hawala Email & Phone Number

Oxford, England, United Kingdom

Responsible for the development and management of outsourced CMC (Chemistry, Manufacturing and Controls) activities for PET radiopharmaceuticals across various stages of drug development. Key responsibilities include driving CMC strategy, managing third-party CDMO partnerships, ensuring compliance with GMP/GDP quality standards, and contributing to project.

Greater London, England, United Kingdom

• Commission, validate, and analyze PET radiotracers under GMP compliance.
• Perform routine maintenance on lab equipment and infrastructure.
• Maintain accurate production and QC records.
• Serve as liaison between PET production/QC and clinical teams.
• Operate synthesis platforms, QC equipment, and PET Trace Cyclotron.

London, England, United Kingdom

• Utilize the company's Molecular Envelope Technology (MET) platform to develop new products, collaborating with external partners and stakeholders, while leading the Manufacturing production.
• Manage outsourced activities related to Quality Assurance (QA) while ensuring compliance with the company's Quality Management System (QMS).
• Collaborate with cross-functional teams to develop pharmaceutical formulations for Clinical Use.
• Serve as the Head of Manufacturing in the MET production, overseeing GMP-like compliant production, making continuous improvement initiatives, and effectively resolving operational challenges.

Londra, Inghilterra, Regno Unito

Torino, Piemonte, Italia

• Synthesis and characterization of dual PET/NIRF probes for targeting of urokinase receptor;
• In vitro/in vivo evaluation of the synthesized probes.

Piazza Amedeo Ferdinando 3, 10024 Moncalieri (TO)

Responsible of the Quality Control of Technetium-99m Radiopharmaceuticals (Indipendent Consultant)Radiolabelling of White Blood Cells (WBC) with Tc-99m HMPAO (Ceretec)

Torino, Italia

Project Title: "Synthesis of new AAZTA based bifunctional chelators for the development of innovative PET imaging agents".Aims: Design and synthesis of novel AAZTA derivatives suitable for the conjugation with peptides or other relevant molecular vectors, to be included in a ‘cold kit’, which allows the subsequent complexation with different positron.

Via Nizza 52 - 10126 - Turin

Project: Use of the chelating agents and related complexes with Gallium 68 for the production of PET imaging probes in molecular imaging applicationsMain activities: Organic Synthesis, Solid Phase Peptide Synthesis, Purifications, Desalting, Characterization, Metal complexations;Instrumental skills: HPLC, LC-MS, NMR 600 MHz, AKTA Purifier, CEM-Liberty.

Project: Use of the chelating agents and related complexes with Gallium 68 for the production of PET imaging probes in molecular imaging applications

Main Activities: HPLC and GC analysis, Potentiometric titration, KF analysis, Dissolution tests

Main Activities: Analytical Method Validations, Common Technical Document for the registration of Pharmaceutical for Human Use writing (CTD), Preformulation studies.

Torino, Italia

Title: Synthesis, characterization and preclinical evaluation of a new nanocarrier for PET tracersActivities: - Analysis HPLC, MS, LC/MS, TLC;- In vivo biodistribution studies: PET/CT;- Labelling with Gallium 68;

Rivalta Di Torino

• Prescription;
• Monthly Health service billing;
• Pharmacy warehouse handling;
• Galenic formulations;
• Management of drugs orders from the hospital

Doctor Of Philosophy - Phd, Pharmaceutical And Biomolecular Sciences, With Honors

Doctor Of Pharmacy (Pharmd), Chemistry And Pharmaceutical Technologies

Associate'S Degree, Farmacia